VTE Prophylaxis for High-Risk Ambulatory Cancer Patients? - Medscape

VTE Prophylaxis for High-Risk Ambulatory Cancer Patients?  Medscape

The use of direct oral anticoagulants for the prevention of venous thromboembolism (VTE) in high-risk ambulatory cancer patients showed promising results in ...



Comments

Post a Comment

Popular posts from this blog

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma - Global Banking And Finance Review

Celgene Corporation Announces POMALYST® Granted Breakthrough Therapy Designation from FDA for HIV-Positive and Negative Kaposi Sarcoma    Global Banking And Finance Review Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to ...
Read more